Comments
Lasa Supergenerics has received WHO-GMP certificate for the unit situated at Mahad, Maharashtra, from the Commissioner of Food and Drug Administration. Following this, the entry to regulated business markets will commence shortly, the company said in a statement to the stock exchanges. The certificate is valid (for active pharmaceutical ingredients - bulk drugs) till April 2020. Investors and shareholders of the company will track the development.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.